ALB and Cirrhosis: Terlipressin increases the afterload and end-diastolic volume with a concurrent reduction in cardiac index7,25. This may unmask the pre-existing cardiac dysfunction in patients with cirrhosis and lead to volume overload and pulmonary edema, particularly if large amounts of albumin are administered concomitantly.